MENU
RVMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Revolution Medicines (RVMD) Earnings Date & Reports
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers... Show more
A.I. Advisor
published Earnings
RVMD is expected to report earnings to fall 20.92% to -242 cents per share on November 11
Q3'26
Est.
$-2.42
Q2'26
Missed
by $1.10
Q1'26
Missed
by $0.46
Q4'25
Missed
by $0.28
Q3'25
Missed
by $0.20
The last earnings report on August 05 showed earnings per share of -305 cents, missing the estimate of -196 cents. With 391.49K shares outstanding, the current market capitalization sits at 41.34B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.
Industry Biotechnology
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
883
Web
https://www.revmed.com